MedTrace Logo

Study of the Cleavage of the Egg in Relation to the Stimulation Treatment

NCT01674894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 356

Last updated 2017-08-28

No results posted yet for this study

Summary

This post-marketing, single-center prospective study will be conducted in an open-label, non-interventional setting, for women seeking fertility treatment and will describe cleavage dynamics in relation to the age of the oocyte and gonadotrophin treatment.

Conditions

  • Female Infertility

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
38 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-12-10
Completion
2016-03-10

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01674894 on ClinicalTrials.gov